Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily approved by the FDA for managing type 2 diabetes mellitus and, in some cases, chronic weight management
11, 12, 13, 93, 94 Nevertheless, this mechanism has still to be validated outside the LS
Mioduchoski, FNP-BC, Board-Certified Family Nurse Practitioner specializing in integrative wellness, medical weight loss, and anti-aging therapies Worried about the potential risks and side effects of peptide therapy
Disclaimer: This blog post is for informational purposes only and should not be construed as medical advice
Endogenous GLP-1 is rapidly degraded primarily by dipeptidyl peptidase-4 (DPP-4), as well as neutral endopeptidase 24 } : CS1 maint: DOI inactive as of July 2026 (link) Journal of Diabetes